Cardiotube Interview: LBCT: Real-World Reintervention Rate Among TAVR Low-Risk Medicare Patients

Sunday, March 8, 2026

1:00 PM - 1:15 PM EST

Location: Lobby Level - Next to Speaker Ready

Interviewer(s)

Toby Rogers, MD, PhD

Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease
Georgetown University and MedStar Washington Hospital Center
Washington, District of Columbia, United States

Disclosure(s): Abbott: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Transmural Systems: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing)

Interviewee(s)

Robert W. Yeh, MD, MSc

Professor of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); CathWorks: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Life Sciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Elixir Medical Corporation: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):

Toby Rogers, MD, PhD: Abbott: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Transmural Systems: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing)

Robert W. Yeh, MD, MSc: Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); CathWorks: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Life Sciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Elixir Medical Corporation: Consulting Fees (e.g., advisory boards) (Ongoing)